-
8 Key Principles to Building a Board of Directors
There are too many great ideas that never reach the surface in our industry and that’s where Kineticos’ newest family -
The FDA’s Shift from Gate Keeper to Enabler
Most of us were shocked when Scott Gottlieb stepped down from his duties as the FDA Commissioner. He is largely -
A Look Inside the Diagnostics Market
The life science ecosystem is a complex organism being influenced by patients, providers, payers, and regulators in the precision medicine, -
Product Launch Metrics
Written by Bill Finger, Executive Vice President & Managing Director, Kineticos With the culmination of a product created through open -
Staying the Course
Written by Mark Osterman, Senior Vice President, Kineticos Kineticos recently announced Q4 2015 results of the Biopharma CEO Confidence Index, -
Central Laboratories Holy Grail: Six Keys to Achieving Preferred Provider Status with BioPharmaceutical Companies
Article Preview A critical growth driver for most any central laboratory is its ability to gain preferred provider agreements (PPAs):
Understanding the Ecosystem for Precision Medicine Companies
The precision medicine industry is growing in importance in the eyes of biopharmaceutical companies and healthcare providers. Initially, diagnostics were viewed as a way to diagnose disease. This has evolved to include companion diagnostic and personalized medicine opportunities that enhance our ability to predict disease and identify response in patients.
The Precision Medicine Practice at Kineticos
The Precision Medicine practice at Kineticos helps diagnostic companies—including labs and tools companies—maximize their commercial potential at the corporate and product levels while ensuring companies operate in an efficient manner. Our team of industry experts has a technical and commercial understanding of diagnostic technologies such as molecular diagnostics, mass spectrometry, flow cytometry, immunoassay, multiplex technology, and next generation sequencing. This enables Kineticos to employ an innovative approach in each project.
The Precision Medicine practice at Kineticos supports clients across three service areas including:
Corporate Strategy and Development
- Market, Competitor, Customer Assessments
- Go-to-Market Strategy
- Licensing and Acquisitions
Technology and Innovation
- Technology Assessment
- R&D Innovation Strategy
- Co-Development Models
Operational Excellence
- Gap Analysis and Best Practice Implementation
- Process Improvement
- Post Merger Integration
Click the Tabs Below for Precision Medicine Practice Case Studies, White Papers and Articles, and Blog
-
Go-to-Market Strategy and Tactical Deployment Plan
Situation: A privately held emerging biotech company, with an innovative cancer detection test, retained Kineticos to assist them in effectively -
Voice of Customer Study
Situation: A joint venture between two European companies was looking to maximize the commercial potential of its automated plate reader -
Go-To-Market Strategy
Situation: As a follow up to a pricing study, Kineticos was retained by a specialty laboratory to develop a comprehensive -
Business Development & Licensing
Situation: An innovative oncology diagnostics company retained Kineticos to assist in developing their pitch deck, as well as developing and -
Diagnostics Partnering Support
Situation: An emerging oncology diagnostics company was in need of a Business Development strategy and retained Kineticos to develop such -
Pricing Strategy
Situation: A global central laboratory services company was considering implementing a price increase across their lab services and requested Kineticos
-
How Metrics Can Help Identify and Solve Operational Challenges
Article Preview As the sophistication of operational practices across life sciences increases; unfortunately, so do the difficulty and complexity of -
Growth by Acquisition in Life Sciences: Do You Have a Plan?
Article Preview As the life sciences landscape continually changes, growth by acquisition has become increasingly common. Recent deals, such as -
Next Generation Sequencing: Using Technology to Develop Mutually-Beneficial Partnerships
Article Preview Arup Laboratories announced it will begin offering next-generation sequencing (NGS) based high resolution Human Leukocyte Antigen (HLA) genotyping -
Role of Companion Diagnostics in Immuno-oncology Race Unfolding
Article Preview Important oncology events, including ASCO and ESMO, have recently displayed the fruits of the huge investment drug companies -
Merck KGaA Announces Acquisition of Sigma-Aldrich, Increasing Lab Supply Division Growth
Article Preview Germany’s Merck KGaA has announced the acquisition of Sigma-Aldrich Corporation, a global life sciences tools (LST) firm, based -
Outsourcing as Opportunity
Article Preview An article published in FiercePharma discussed the top 10 largest pharma layoffs in 2013. Whenever layoffs are announced